DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Baldelli R, Colao A, Razzore P. et al.
2-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg).
J Clin Endocrinol Metab 2000; 85: 4099-4103
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.